DeepMed Research

Fudan University

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1905-01-01

Employees: 1K

Market Cap: -

Website: http://www.fudan.edu.cn

Clinical Trials

Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases

Phase 3

Recruiting

Conditions: Liver Metastases
Colorectal Cancer

Interventions: Drug: mFOLFOXIRI plus Cetuximab
Drug: mFOLFOXIRI Plus Bevacizumab

First Posted Date: 2020-12-29

Last Posted Date: 2024-12-18

Lead Sponsor: Fudan University

Target Recruit Count: 508

Registration Number: NCT04687631

Locations: 🇨🇳
Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China

Microwave Ablation Combined With Chemotherapy in the Treatment of Pancreatic Cancer Oligohepatic Metastasis

Phase 2

Conditions: Pancreatic Cancer Metastatic to Liver
Oligometastasis

Interventions: Combination Product: Microwave Ablation combination with chemotherapy

First Posted Date: 2020-12-21

Last Posted Date: 2020-12-21

Lead Sponsor: Fudan University

Target Recruit Count: 50

Registration Number: NCT04677192

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Diagnostic Accuracy of CCTA-derived Versus AngiogRaphy-dErived QuantitativE Flow Ratio (CAREER) Study

Conditions: Coronary Artery Disease
Hemodynamics
Coronary Computed Tomography Angiography
Coronary Stenosis

First Posted Date: 2020-12-14

Last Posted Date: 2022-01-25

Lead Sponsor: Fudan University

Target Recruit Count: 216

Registration Number: NCT04665817

Locations: 🇨🇳
Xinkai Qu, Shanghai, Shanghai, China

Clinical Efficacy and SAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary Intervention

Phase 4

Completed

Conditions: ST Elevation Myocardial Infarction
Percutaneous Coronary Intervention

Interventions: Drug: Placebo
Drug: Nicorandil

First Posted Date: 2020-12-11

Last Posted Date: 2025-03-11

Lead Sponsor: Fudan University

Target Recruit Count: 1500

Registration Number: NCT04665648

Locations: 🇨🇳
Zhongshan Hospital, Shanghai, Shanghai, China

Effect of Chewing Gum and Mouthwash Before Operation on Sore Throat After General Anesthesia With a Laryngeal Mask

Not Applicable

Conditions: Postoperative Sore Throat

Interventions: Other: Mouthwash
Other: chewed mint gum

First Posted Date: 2020-11-25

Last Posted Date: 2020-11-25

Lead Sponsor: Fudan University

Target Recruit Count: 70

Registration Number: NCT04644900

Locations: 🇨🇳
Ethics Committee of The Obstetrics and Gynecology Hospital, Fudan University,, Shanghai, China

The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in Oligometastatic Gastrointestinal Cancer

Phase 1

Conditions: Oligometastatic Gastrointestinal Cancer

Interventions: Radiation: Stereotactic Ablative Radiotherapy (SABR)
Drug: Camrelizumab for injection (200 mg, iv), D1, Q2W, 14-day cycle

First Posted Date: 2020-11-12

Last Posted Date: 2020-11-12

Lead Sponsor: Fudan University

Target Recruit Count: 21

Registration Number: NCT04625894

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic Cancer

Phase 3

Recruiting

Conditions: Borderline Resectable Pancreatic Cancer
Locally Advanced Pancreatic Adenocarcinoma

Interventions: Drug: mFOLFIRINOX
Drug: Nab paclitaxel plus gemcitabine

First Posted Date: 2020-11-05

Last Posted Date: 2022-01-28

Lead Sponsor: Fudan University

Target Recruit Count: 300

Registration Number: NCT04617821

Locations: 🇨🇳
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University, Shanghai, Shanghai, China

Effects of One-handed and Two-handed Mask Ventilation Techniques on Global and Regional Lung Ventilation

Not Applicable

Conditions: Anesthesia

Interventions: Other: Two-handed mask ventilation
Other: One-handed mask ventilation

First Posted Date: 2020-11-05

Last Posted Date: 2020-11-05

Lead Sponsor: Fudan University

Target Recruit Count: 80

Registration Number: NCT04617665

Accuracy of VABB Elite 10G Versus BARD 14G CNB

Phase 3

Conditions: Breast Cancer

Interventions: Device: VABB Elite 10G
Device: BARD 14G CNB

First Posted Date: 2020-11-03

Last Posted Date: 2021-09-14

Lead Sponsor: Fudan University

Target Recruit Count: 1470

Registration Number: NCT04612439

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China

Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer

Phase 2

Conditions: Thyroid Cancer

Interventions: Drug: Camrelizumab and Apatinib
Procedure: surgery
Procedure: core needle biopsy

First Posted Date: 2020-11-03

Last Posted Date: 2020-11-03

Lead Sponsor: Fudan University

Target Recruit Count: 31

Registration Number: NCT04612894

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy